Pfizer’s Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.
| Title
Sort ascending
|
Grant Type |
Focus Area |
Country |
Application Due Date |
|---|---|---|---|---|
RSV Infection and RSV Maternal Immunization in Area of Obstetrics and Gynecology
Release Date:
|
Education | Vaccines | Japan | |
Transthyretin Cardiac Amyloidosis Fellowship
Release Date:
|
Fellowship | Rare Disease | USA | |
|
Release Date:
|
Education | Internal Medicine | USA | |
Develop Young Physicians to Lead the Increase in Preventive Awareness by Vaccination
Release Date:
|
Education | Vaccines | Japan | |
Optimizing maternal immunization practice and vaccination access during pregnancy in Italy
Release Date:
|
Quality Improvement | Vaccines | Italy | |
Sickle Cell Disease (SCD) Fellowship
Release Date:
|
Fellowship | Rare Disease | USA | |
Quality Improvement Grants to Support Development of Cardiac Amyloid Centers
Release Date:
|
Quality Improvement | Rare Disease | USA | |
Increasing Awareness and Understanding of Amyloid Transthyretin Cardiomyopathy (ATTR-CM)
Release Date:
|
Education | Rare Disease | USA | |
Quality Improvement Grants to Improve Identification and Management of Patients with ATTR Amyloidosis
Release Date:
|
Quality Improvement | Rare Disease | Spain | |
2024 Raising Awareness and Promoting Timely Diagnosis of TTR Amyloidosis
Release Date:
Partner: Global Bridges at Mayo Clinic
|
Quality Improvement | Rare Disease | All | |
Improving the care and outcomes of residents of Canada living with metastatic NSCLC
Release Date:
Partner: Lung Health Foundation, Lung Cancer Canada, Quebec Lung Association
|
Quality Improvement | Oncology | Canada | |
Closing the HRRm Testing Gap in Prostate Cancer Patients
Release Date:
|
Quality Improvement | Oncology | Canada |
| Title
Sort ascending
|
Grant Type |
Focus Area |
Country |
Application Due Date |
|---|---|---|---|---|
Accelerate Promotion and Dissemination of Appropriate Atopic Dermatitis Diagnosis, Treatment, and Management Guidance
Release Date:
Partner: Japanese Dermatological Association
|
Quality Improvement | Inflammation & Immunology | Japan | |
Vaccines for All: Longevity Unleashed for Everyone (VALUE)
Release Date:
|
Quality Improvement | Vaccines | Japan | |
UK Oncology Quality Improvement Grants
Release Date:
|
||||
Treatment Patterns of CDK 4/6 Inhibitor Utilization in HR+/HER2- Metastatic Breast Cancer
Release Date:
|
||||
Translating the Atopic Dermatitis (AD)
Release Date:
|
||||
Supporting Educational Programs for Radical Reform of Pain Treatment in Japan
Release Date:
|
||||
Rheumatology Nurse Practitioner and Physician Assistant Fellowship
Release Date:
|
||||
Raising Awareness and Promoting Timely Diagnosis of TTR Amyloidosis
Release Date:
|
Quality Improvement | Rare Disease | All | |
Quality Improvement initiatives optimizing AF and VTE management in Canada
Release Date:
|
||||
Quality Improvement Grants to Support Development of Cardiac Amyloid Centers
Release Date:
|
||||
Quality Improvement Grants to Support Development of Cardiac Amyloid Centers
Release Date:
|
||||
Quality Improvement Activities to Prevent Fatal Pulmonary Thromboembolism
Release Date:
|